Who owns NEUROSENSE THERAPEUTICS LTD?
- Ticker: NRSN
- CUSIP Number: m74240108
Tip: Access positions for across all investors
Analyze quarterly positions in Neurosense Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurosense Therapeutics stock
Who bought or sold NEUROSENSE THERAPEUTICS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 1.6M | $1.8M | 100% | Jun 2024 |
|
| Cantor Fitzgerald, L. P. | 80k | $101k | 100% | Sep 2024 |
|
| Meitav Dash Investments | 40k | $51k | 0% | Sep 2024 |
|
| Citadel Advisors | 34k | $44k | 100% | Sep 2024 |
|
| Commonwealth Equity Services | 13k | $16k | 100% | Sep 2024 |
|
| Geode Capital Management | 12k | $15k | 0% | Sep 2024 |
|
| Morgan Stanley | 1.5k | $1.7k | 0% | Jun 2024 |
|
| CWM | 1.0k | $1.0k | 0% | Sep 2024 |
|
| Qube Research & Technologies | 54.00 | $59.999400 | 0% | Jun 2024 |
|
Who sold out of Neurosense Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Jun 2024 | 33k | $37k |